This review analyzes glucocorticoids' effect on glial neurotrophic factor in ischemic stroke, suggesting potential neuroprotective pathways.
Glial neurotrophic factor (GDNF) was first identified as a survival factor of dopaminergic neurons, but was further shown to be a neurotrophic factor for neurons of the central and peripheral nervous systems. GDNF signaling is via transmembrane GFRα1 co-receptor tyrosine kinase RET receptors or via nerve cell adhesion protein (NCAM) and promotes neuronal survival, neurite growth and synaptogenesis. Under physiological conditions, GDNF is expressed in neurons, but as a result of ischemic stroke, its synthesis occurs mainly in activated astrocytes. In this review, in addition to general information on neurotrophic factor, we tried to analyze data on the effect of ischemic stroke on GDNF, on the mechanisms of its neuroprotective action, and speculate on the possible effect of glucocorticoids on activated astrocytes and GDNF production in stroke.
No takes yet. Share an insight, caveat, or question.
M. V. Onufriev (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: